Essential oils in the treatment of intestinal dysbiosis: A preliminary in vitro study

Alternative Medicine Review

Volumn 14, Issue 4, 2009, Pages 380-384

  Hawrelak, Jason A ^a   Cattley, Trudi ^b   Myers, Stephen R ^a  

^a SOUTHERN CROSS UNIVERSITY   (Australia)

^b Australian Centre for Complementary Medicine Education and Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CITRUS OIL; ESSENTIAL OIL; PEPPERMINT OIL;

AGAR DILUTION; ARTICLE; BACTERIAL GROWTH; CARAWAY; CONTROLLED STUDY; DRUG SELECTIVITY; ENTEROPATHY; FENNEL; ILLICIUM VERUM; IN VITRO STUDY; INTESTINAL DYSBIOSIS; INTESTINE FLORA; LAVANDULA ANGUSTIFOLIA; LAVENDER; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SOUR ORANGE; TRACHYSPERMUM COPTICUM;

ANTI-BACTERIAL AGENTS; BACTERIA; CARUM; CITRUS; CORIANDRUM; FOENICULUM; HUMANS; INTESTINAL ABSORPTION; INTESTINAL DISEASES; MENTHA PIPERITA; OILS, VOLATILE; PHYTOTHERAPY; PLANT OILS;

EID: 74049131056     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern Med Rev 2004;9:180-197.
2. Bjorksten B, Sepp E, Julge K, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-520.
3. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129-134.
4. Peltonen R, Nenonen M, Helve T, et al. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br J Rheumatol 1997;36:64-68.
5. Onderdonk AB. Role of the intestinal microflora in ulcerative colitis. In: Hentges DJ, ed. Human Intestinal Microflora in Health and Disease. New York, NY: Academic Press; 1983:481-493.
6. Linskens RK, Huijsdens XW, Savelkoul PH, et al. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 2001;234:29-40.
7. Balsari A, Ceccarelli A, Dubini F, et al. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982;5:185-194.
8. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004;10:1802-1805.
9. Mahnen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373-382.
10. Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998;10:59-62.
11. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-406.
12. Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999;318:565-566.
13. Alun Jones V, Wilson AJ, Hunter JO, et al. The aetiological role of antibiotic prophylaxis with hysterectomy in irritable bowel syndrome. J Obstet Gynaecol 1984;5:S22-S23.
14. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998;352:1187-1189.
15. Treem WR, Ahsan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996;23:280-286.
16. Halpern GM, Prindiville T, Blankenburg M, et al. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996;91:1579-1585.
17. Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. AmJ Gastroenterol 2000;95:1231-1238.
18. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299 V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001;13:1143-1147.
19. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004;38:S104-S106.
20. Conway PL. Microbial ecology of the human large intestine. In: Gibson GR, Macfarlane GT, eds. Human Colonic Bacteria: Role in Nutrition, Physiology, and Pathology. Boca Raton, FL: CRC Press; 1995:1-24.
21. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E.DEF 3.1, June 2000: Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infect 2000;6:509-515.
22. Mills S, Bone K. Principles and Practice of Phytotherapy. Edinburgh, UK: Churchill Livingstone; 2000:507-514.
23. van Wyk BE, Wink M. Medicinal Plants of the World. Pretoria, South Africia: Briza Publications; 2004:82.
24. van Wyk BE, Wink M. Medicinal Plants of the World. Pretoria, South Africa: Briza Publications; 2004:145.
25. van Wyk BE, Wink M. Medicinal Plants of the World. Pretoria, South Africa: Briza Publications; 2004:205.
26. van Wyk BE, Wink M. Medicinal Plants of the World. Pretoria, South Africa: Briza Publications; 2004:180.
27. Bone K. A Clinical Guide to Blending Liquid Herbs. Edinburgh, UK: Churchill Livingstone; 2003:304-307.
28. Bensky D, Clavey S, Stoger E, Gamble A. Chinese Herbal Medicine Materia Medica, 3rd ed. Seattle, WA: Eastland Press; 2004:510-516.
29. Williamson EM. Major Herbs of Ayurveda. Edinburgh, UK: Churchill Livingstone; 2002:306-310.
30. Liu JH, Chen GH, Yeh HZ, et al. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol 1997;32:765-768. 31. Dew MJ, Evans BK, Rhodes J. Peppermint oil for the irritable bowel syndrome: a multicentre trial. Br J Clin Pract 1984;38:394,398.
31. Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr 2001;138:125-128.
32. Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998;80:S209-S212.
33. Tannock GW Molecular assessment of intestinal microflora. AmJ Clin Nutr 2001;73:410S-414S.